Slightly, on average, but the effect is modest
Xue X, Zhang W, Zhu J, Chen X, Zhou S, Xu Z, et al
Furthermore, there may be concerns regarding the long-term safety profile and uncommon adverse effects associated with GLP-1 receptor agonists, which may limit their use in specific patient populations
Stabilitt & Halbwertszeitdaten Plasmahalbwertszeit: Etwa 30 Minuten nach intraperitonealer Verabreichung in pharmakokinetischen Nagetierstudien
By boosting insulin release and decelerating food digestion, it functions as an effective weight loss injection, curbing appetite and reducing food consumption, thereby making it a preferred choice for weight loss injections in the community